General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-08 | 2023-09 | -0.29 | N/A | N/A | N/A |
2023-08-10 | 2023-06 | -0.53 | N/A | N/A | N/A |
2023-05-10 | 2023-03 | -0.8 | N/A | N/A | N/A |
2023-03-30 | 2022-12 | -0.1 | N/A | N/A | N/A |
2022-11-14 | 2022-09 | -1.2 | N/A | N/A | N/A |
2022-08-11 | 2022-06 | -1.2 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-01 | Alliance Global Partners | Upgrade | Buy | |
2023-09-24 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-17 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-09 | ADAMS ADRIAN | Director | 11.17K | Stock Award(Grant) |
2023-10-09 | AFABLE RICHARD | Director | 2.47K | Stock Award(Grant) |
2023-12-12 | ANGOTTI VINCENT J | Chief Executive Officer | 101.81K | Purchase |
2023-10-09 | BOZILENKO MARINA | Director | 2.61K | Stock Award(Grant) |
2023-10-09 | BROADFOOT JILL MARIE | Director | 2.11K | Stock Award(Grant) |
2023-02-09 | DASU BADRI N | Officer | 19.17K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Rock Springs Capital Management, LP | 316.46K | 351.27K | 1.94% |
2023-06-29 | Tang Capital Management, LLC | 195.00K | 216.45K | 1.19% |
2023-06-29 | Vanguard Group Inc | 157.51K | 174.83K | 0.96% |
2023-06-29 | Values First Advisors, Inc. | 122.44K | 135.91K | 0.75% |
2023-06-29 | Blackrock Inc. | 92.09K | 102.22K | 0.56% |
2023-06-29 | Geode Capital Management, LLC | 68.90K | 76.48K | 0.42% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 112.87K | 125.29K | 0.69% |
2023-06-29 | Vanguard Extended Market Index Fund | 37.37K | 41.48K | 0.23% |
2023-05-30 | Fidelity Extended Market Index Fund | 30.22K | 30.10K | 0.18% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 12.37K | 13.73K | 0.08% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.92K | 9.88K | 0.06% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 7.49K | 7.46K | 0.05% |
Split | Date |
---|---|
1 : 20 | 2022-10-26 |
Set mental stops
Real stops just feed the shorts
Stock pin
Go ahead and said that stop loss at $.99
Almost guarantees the market makers will grab your shares cheap
Mr Holcomb
You stay short a $1 stock right up to the time Cleveland Clinic announces results of investigator initiated study
Or maybe Brigham and women’s hospital
Take your pick of any one of five studies. You just stay short for those announcements.
You are also betting against Zimmer Biomet. That’s always been a good move
Your piercing arrogance will melt quickly
And how about we do a straight up bet on that bankruptcy thing huh
Have a nice day
HATERSSS GONNA HATE
Really like to meet the folks who think selling this stock at 1.14 is good move
Did you not take math in school?
Lisa
Can I say you have lost a good deal of credibility
Yesterday this company was run by crooks who should be in jail
Today it’s brilliant science you post. Will the real lisa fl please stand up?
BTW how did your trade go in TRVN?
Hey Lisa
What happened to your enthusiasm for FOUR investigator initiated studies by The Cleveland Clinic, Brigham & Women’s hospital etc
The studies are still in place my friend end of the Cleveland clinic study ever drops you might regret moving to Trevena
Mr Holcomb
Appreciate your sage advice
You clearly do not own here so the fact you would come back simply to warn us is a credit to your humanity and compassion
Heartwarming
Just a friendly CPA who, unlike you, can see further than three months down the road
I cannot wait for the Cleveland clinic study to drop and rip the faces of the short sellers
Hey shot go buy some Zoom
Nik can speak without turd coming from his mouth
Who knew? I miss the seven year old Nik
Hey Nik
Where were you yesterday?
Can’t say we missed you
I am a CPA. Let us remember
Existing institutional investors just bought $10,000,000 worth of this stock at 1.20
One assumes they had best info available. They clearly see the long-term value of the Zimmer Biomet partnership
I just bought 2000 more shares
Zimmer Biomet thinks they can sell it. They are spending money to train 250 of their own reps to sell this product to more than 7000 physicians in their sphere
Zimmer Biomet is not stupid
Rman
The direct offering price was 1.20
Did do you want to sell me your shares at $1.20 I will take them
Understand what you are talking about before you ask us to inundate the CEO is stupid emails
Sorry Clarissa
$ACRX The only turds in a bowl I can think of would be Nik and Carlissa what do u think